Delivery Order SPE2DB20D1100-SPE2DB25FD8D2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units, with a ceiling value of $3,176.22 and a completion date of July 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is executed as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global...
- The Defense Logistics Agency awarded a delivery order valued at $10,560.80 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units, with a ceiling value of $21,823.23. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through competitive procurement. The contract is scheduled for ultimate completion on July 24, 2025, with performance to be conducted at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $4,700.52 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract for pharmaceutical supply to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units, with a contract ceiling value of $5,094.43. The award represents a firm fixed-price delivery order with no set-aside designation, indicating competitive procurement through open competition. This delivery order is a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $2,981.76 delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 22, 2025, with a completion date of July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be fulfilled at the vendor's Conshohocken, Pennsylvania location. The delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Vemlidy 25 mg tablets in a quantity of 30 units, with a ceiling value of $10,849.10 and a firm fixed price. This is a non-set-aside competitive award with an ultimate completion date of July 31, 2025. The contract is performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $10,710.30 for Vemlidy 25 mg tablets (30-count units) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $1,252.42 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract involves no set-aside designation and is scheduled for completion by July 25, 2025,...
- The Defense Logistics Agency awarded a $3,914.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This is a non-set-aside competitive award representing a child order under AmerisourceBergen's larger contract vehicle with DLA. Vemlidy is an antiviral medication, and this delivery order reflects AmerisourceBergen's role as a critical pharmaceutical supplier supporting...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD8D2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Vemlidy 25 mg tablets in a quantity of 30 units, with a contract ceiling value of $3,713.42. This is a firm fixed price delivery order with no set-aside designation, awarded competitively through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. This delivery order represents a routine pharmaceutical procurement under AmerisourceBergen's larger SPE2DX Indefinite Delivery Contract, a $999,999,999 global pharmaceutical support vehicle that runs through December 2026. As a major pharmaceutical distributor, AmerisourceBergen supplies critical medical commodities including brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare programs and the Defense Health Agency. The Vemlidy tablets being procured under this delivery order support the company's role as a key vendor in the DLA's medical supply chain, fulfilling routine pharmaceutical needs for federal military and healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 8/4/25 |